Acumen Research Laboratory
Molecular diagnostic tools for infectious disease detection
About Acumen Research Laboratory
Acumen Research Laboratories (ARL) is a Singapore-based life sciences company specializing in biomarker discovery and the development of molecular diagnostic tools for infectious diseases. Founded in 2010 by Dr. Ong Siew Hwa, the company operates as a contract research organization (CRO), offering R&D services to the pharmaceutical and biomedical science sectors. Dr. Ong, who holds a Ph.D. in cell and molecular biology, has extensive experience in pharmaceutical R&D and molecular diagnostics and has served as an adjunct assistant professor at the National University of Singapore's Yong Loo Lin School of Medicine.
The company's primary business involves developing and manufacturing PCR-based, culture-independent molecular diagnostic tests. ARL's portfolio includes the patented AcuSept test, a host-response test that uses a panel of mRNA biomarkers to detect sepsis within five hours, a significant improvement over traditional methods. This test is also relevant as a companion diagnostic in sepsis treatment and for guiding clinical trials. In response to the COVID-19 pandemic, ARL developed the Acu-Corona PCR test kits. The company also distributes the Unyvero platform, which detects pathogens and antibiotic resistance markers for conditions like pneumonia, intra-abdominal infections, and blood infections. ARL's client base includes companies developing new antibiotics, diagnostics, and medical devices.
In 2020, Acumen Diagnostics was established as a joint venture with Q & M Dental Group, focusing on rapid PCR-based tests. This entity became a key provider of COVID-19 PCR testing in Singapore. Acumen Research Laboratories was acquired by Aoxin Q&M Dental Group on October 9, 2021, for $29.4 million. However, as of late 2024, Q&M Dental Group decided to suspend Acumen's laboratory business due to its loss-making position following the shift away from mass COVID-19 testing.
Source: Dealroom company dataAt a glance
- Founded
- 2010
- Headquarters
- China
- Sector
- Health
News
Open roles
Acumen Research Laboratory in its local ecosystem
The Acumen Research Laboratory office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Aoxin Q&M Dental Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Acumen Research Laboratory on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Acumen Research Laboratory on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
